Janux Therapeutics, Inc.
Janux Therapeutics, Inc. scores highest on Torque (69) and lowest on Earnings (24). Its PosiPenta is 42.13 out of 100, around the middle of similar companies.
On the Penta Grid this week, Janux Therapeutics, Inc. is Grid #466 of 837 in the Healthcare sector in United States, and Grid #2,681 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | 42.13 | 38 | 24 | 45 | 69 | 34 |
| Beta Bionics, Inc. | 40.81 | 19 | 26 | 53 | 64 | 42 |
| Lumexa Imaging Holdings, Inc. | 50.32 | 31 | 80 | 58 | 12 | 70 |
| Harrow, Inc. | 37.83 | 1 | 72 | 32 | 13 | 71 |
| MannKind Corporation | 54.25 | 0 | 81 | 45 | 99 | 46 |
| HealthStream, Inc. | 68.54 | 33 | 59 | 96 | 71 | 83 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -10.07 |
| P/B ratio | 1.09 |
EEarnings
| Trailing EPS | ₹-155.33 |
| Forward EPS | ₹-248.53 |
NNitro
| Price | 1563.74 |
| 52-week high | 3347.23 |
| 52-week low | 1147.95 |
| Fall from 52-week high | 53.3% |
TTorque
| Return on equity (ROE) | -10.70% |
| Debt-to-equity | 0.02 |
AAnchor
| Beta (price swings) | 2.39 |
| Market cap | ₹9,560 Cr |
| Insider holding | 0.99% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Janux Therapeutics, Inc.'s PosiPenta score?
Janux Therapeutics, Inc.'s PosiPenta is 42.13 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Janux Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Janux Therapeutics, Inc. is Grid #466 of 837 in the Healthcare sector in United States, and Grid #2,681 of 4,000 in United States.
Which PosiPenta pillar is strongest for Janux Therapeutics, Inc.?
Torque (durability), with a score of 69 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Janux Therapeutics, Inc.?
Earnings (growth), with a score of 24 out of 100: weaker than most similar companies.
Has Janux Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.68 points, from 39.45 to 42.13.
PositoAI is for research and education only and is not investment advice.